ANTISENSE MODULATION OF INTERFERON GAMMA RECEPTOR 2 EXPRESSION

Details for Australian Patent Application No. 2002307350 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors BENNETT, C., Frank; WATT, Andrew, T.

Pub. Number AU-A-2002307350

PCT Number PCT/US02/12007

PCT Pub. Number WO2002/088163

Priority 09/843,377 26.04.01 US

Filing date 16 April 2002

Wipo publication date 11 November 2002

International Classifications

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 015/00 Mutation or genetic engineering

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/843,377 26.04.01 US

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002307350

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307351-PRODRUGS OF COX-2 INHIBITORS

2002307349-ANTISENSE MODULATION OF INTERFERON GAMMA RECEPTOR 1 EXPRESSION